Advances in Cutaneous Squamous Cell Carcinoma Management
cSCC is increasing in prevalence due to increased lifespans and improvements in survival for conditions that increase the risk of cSCC. The absolute mortality of cSCC exceeds melanoma in the United States and approaches that of melanoma worldwide. This review presents significant changes in the mana...
Main Authors: | Carrick Burns, Shelby Kubicki, Quoc-Bao Nguyen, Nader Aboul-Fettouh, Kelly M. Wilmas, Olivia M. Chen, Hung Quoc Doan, Sirunya Silapunt, Michael R. Migden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/15/3653 |
Similar Items
-
Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma
by: Olivia M. Chen, et al.
Published: (2022-07-01) -
Immunosuppression is a risk factor for worse survival and disease‐specific death in cutaneous squamous cell carcinoma
by: Adina Greene, et al.
Published: (2024-03-01) -
Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
by: Marina Rezende de Fázio, et al.
Published: (2023-08-01) -
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
by: T. Van Meerhaeghe, et al.
Published: (2022-10-01) -
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
by: T. Van Meerhaeghe, et al.
Published: (2023-01-01)